NCT04743362 A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
| NCT ID | NCT04743362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Skin Lesion |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,010 participants |
| Start Date | 2021-02-02 |
| Primary Completion | 2031-08-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,010 participants in total. It began in 2021-02-02 with a primary completion date of 2031-08-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to find out whether using noninvasive methods to study the appearance of lesions can improve diagnostic accuracy before a biopsy is required and help guide treatment planning. The database created to store these images is called an Image Repository, and it will be used to support clinical practice, teaching and training, and future research.The High-resolution OCT (Apollo Medical Optics) device ApolloVue® S100 Image System (medical device Class II) can provide both cross-sectional and en-face images with cellular information.
Eligibility Criteria
Inclusion Criteria: * All ages * Patients with a muco-cutaneous lesion(s) amenable to imaging by non-invasive tools * Healthy volunteer subjects * Ability to give informed consent or in the case of pediatric patients, assent and consent from the parent/guardian Exclusion Criteria: * Allergy or intolerance to ultrasound gel or mineral oil used for imaging * Patients who are not able to comply with imaging procedure
Contact & Investigator
Manu Jain, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT04743362 clinical trial?
This trial is open to participants of all sexes, studying Skin Lesion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04743362 currently recruiting?
Yes, NCT04743362 is actively recruiting participants. Contact the research team at jainm@mskcc.org for enrollment information.
Where is the NCT04743362 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04743362 clinical trial?
NCT04743362 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Manu Jain, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 5,010 participants.